DGAP-News: aap Implantate AG / Key word(s): Half Year Results
14.08.2020 / 15:48
The issuer is solely responsible for the content of this announcement.
The COVID-19 pandemic led to a significant impairment of business operations at aap Implantate AG (“aap” or “Company”) in recent months, which is reflected in the development of sales and earnings in the second quarter and first half of 2020. aap achieved sales of EUR 1.9 million in the second quarter of 2020 (Q2/2019: EUR 2.5 million) and EUR 4.4 million in the first six months (H1/2019: EUR 6.0 million). EBITDA was significantly impacted by one-time effects from the ongoing restructuring and refinancing as well as the revision of the quality management system and amounted to EUR -2.1 mi…
Read the full article at: https://www.pharmiweb.com/press-release/2020-08-14/q2-and-h12020-tangible-positive-impact-of-restructuring-on-aap-performance-in-challenging-covid-19
Go to Top Call Now Button